Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

European Journal of Neuroscience

Volumn 31, Issue 4, 2010, Pages 722-732

  Liu, Ming C ^a   Akinyi, Linnet ^a   Scharf, Dancia ^a   Mo, Jixiang ^a   Larner, Stephen F ^a   Muller, Uwe ^a   Oli, Monika W ^a   Zheng, Wenrong ^a   Kobeissy, Firas ^b   Papa, Linda ^c   Lu, Xi Chun ^d   Dave, Jitendra R ^d   Tortella, Frank C ^d   Hayes, Ronald L ^a,b   Wang, Kevin K W ^a,b,e  

^a BANYAN BIOMARKERS INC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c ORLANDO REGIONAL MEDICAL CENTER   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biomarker; Cell death; Diagnosis; Ischemia; Stroke; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; CALPAIN; SPECTRIN; SPECTRIN ALPHA 2; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN CORTEX; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; UBIQUITIN THIOLESTERASE;

EID: 77049106939     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07097.x     Document Type: Article

References (64)

1. Anderson, K.J., Scheff, S.W., Miller, K.M., Roberts, K.N., Gilmer, L.K., Yang, C. Shaw, G. (2008) The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J. Neurotrauma, 25, 1079 1085.
2. Berger, R.P., Adelson, P.D., Pierce, M.C., Dulani, T., Cassidy, L.D. Kochanek, P.M. (2005) Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg., 103 (1 Suppl. 61 68.
3. Berger, R.P., Dulani, T., Adelson, P.D., Leventhal, J.M., Richichi, R. Kochanek, P.M. (2006) Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics, 117, 325 332.
4. Berger, R.P., Beers, S.R., Richichi, R., Wiesman, D. Adelson, P.D. (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma, 24, 1793 1801.
5. Choi, D.W. (2002) Exploratory clinical testing of neuroscience drugs. Nat. Neurosci. (Suppl. 5, 1023 1025. [doi : Bullock, R. (2001) Design and statistical issues in multicenter trials of severe head injury. Neurol. Res., 23, 190 192.
6. Dambinova, S.A., Khounteev, G.A., Izykenova, G.A., Zavolokov, I.G., Ilyukhina, A.Y. Skoromets, A.A. (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem., 49, 1752 1762.
7. Dirnagl, U., Ladecola, C. Moskowitz, M.A. (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci., 22, 391 397.
8. Elkind, M.S. (2003) Stroke in the elderly. Mt. Sinai J. Med., 70, 27 37.
9. Ge, P., Luo, Y., Liu, C.L. Hu, B. (2007) Protein aggregation and proteasome dysfunction after brain ischemia. Stroke, 38, 3230 3236.
10. Hu, B.R., Janelidze, S., Ginsberg, M.D., Busto, R., Perez-Pinzon, M., Sick, T.J., Siesjö, B.K. Liu, C.L. (2001) Protein aggregation after focal brain ischemia and reperfusion. J. Cereb. Blood Flow Metab., 21, 865 875.
11. Ingebrigtsen, T. Romner, B. (2003) Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor. Neurol. Neurosci., 21, 171 176.
12. Jackson, P. Thompson, R.J. (1981) The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci., 49, 429 438.
13. Johnsson, P., Blomquist, S., Lührs, C., Malmkvist, G., Alling, C., Solem, J.O. Ståhl, E. (2000) Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann. Thorac. Surg., 69, 750 754.
14. Johnston, S.C., Riddle, S.M., Cohen, R.E. Hill, C.P. (1999) Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J., 18, 3877 3887.
15. Kobeissy, F.H., Ottens, A.K., Zhang, Z.Q., Dave, J.R., Tortella, F.C., Hayes, R.L. Wang, K.K.W. (2006) Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol. Cell Proteomics, 5, 1887 1898.
16. Kobeissy, F.H., Sadasivan, S., Oli, M.W., Robinson, G., Larner, S.F., Zhang, Z., Hayes, R.L. Wang, K.K.W. (2008) Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin. Appl. 2, 1467 1483.
17. Kwon, J., Mochida, K., Wang, Y.L., Sekiguchi, S., Sankai, T., Aoki, S., Ogura, A., Yoshikawa, Y. Wada, K. (2005) Ubiquitin C-terminal hydrolase L-1 is essential for the early apoptotic wave of germinal cells and for sperm quality control during spermatogenesis. Biol. Reprod., 73, 29 35.
18. Langlois, J.A., Rutland-Brown, W. Thomas, K.E. (2004) Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
19. Larsen, C.N., Price, J.S. Wilkinson, K.D. (1996) Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry, 35, 6735 6744.
20. Larsen, C.N., Krantz, B.A. Wilkinson, K.D. (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry, 37, 3358 3368.
21. Lincoln, S., Vaughan, J., Wood, N., Baker, M., Adamson, J., Gwinn-Hardy, K., Lynch, T., Hardy, J. Farrer, M. (1999) Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport, 10, 427 429. (Pubitemid 29104826)
22. Lumpkins, K.M., Bochicchio, G.V., Keledjian, K., Simard, J.M., McCunn, M. Scalea, T. (2008) Glial fibrillary acidic protein is highly correlated with brain injury. J. Trauma, 65, 778 784.
23. Marin, R., Williams, A., Hale, S., Burge, B., Mense, M., Bauman, R. Tortella, F. (2003) The effect of voluntary exercise exposure on histological and neurobehavioral outcomes after ischemic brain injury in the rat. Physiol. Behav., 80, 167 175.
24. McGinn, M.J., Kelley, B.J., Akinyi, L., Oli, M.W., Liu, M.C., Hayes, R.L., Wang, K.K.W. Povlishock, J.T. (2009) Biochemical, structural and biomarker evidence for calpain-mediated cytoskeletal change following diffuse brain injury uncomplicated by contusion. J. Neuropathol. Exp. Neurol., 68, 241 249.
25. Missler, U., Wiesmann, M., Friedrich, C. Kaps, M. (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 28, 1956 1960.
26. Nath, R., Huggins, M., McGinnis, K., Nadimpalli, D. Wang, K.K.W. (2000) Development and characterization of antibodies specific to caspase-3-produced αII-spectrin 120 kDa breakdown product: marker for neuronal apoptosis. Neurochem. Int., 36, 351 361.
27. Nylén, K., Öst, M., Csajbok, L.Z., Nilsson, I., Hall, C., Blennow, K., Nellgård, B. Rosengren, L. (2008) Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir. (Wein), 150, 221 227.
28. Papa, L., Akinyi, L., Liu, M.C., Pineda, J.A., Tepas, J.J., 3rd., Oli, M.W., Zheng, W., Robinson, G., Robicsek, S.A., Gabrielli, A., Heaton, S.C., Hannay, H.J., Demery, J.A., Brophy, G.M., Layon, J., Robertson, C.S., Hayes, R.L. Wang, K.K. (2010) Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med., 38, 138 144.
29. Pelinka, L.E., Szalay, L., Jafarmadar, M., Schmidhammer, R., Redl, H. Bahrami, S. (2003) Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br. J. Anaesth., 91, 595 597.
30. Pelinka, L.E., Kroepfl, A., Schmidhammer, R., Krenn, M., Buchinger, W., Redl, H. Raabe, A. (2004a) Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma, 57, 1006 1012.
31. Pelinka, L.E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A. Redl, H. (2004b) GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J. Neurotrauma, 21, 1553 1561.
32. Pelinka, L.E., Harada, N., Szalay, L., Jafarmadar, M., Redl, H. Bahrami, S. (2004c) Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock, 21, 72 76.
33. Pelinka, L.E., Hertz, H., Mauritz, W., Harada, N., Jafarmadar, M., Albrecht, M., Redl, H. Bahrami, S. (2005) Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock, 24, 119 123.
34. Petzold, A. (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci., 233, 183 198.
35. Petzold, A. Shaw, G. (2007) Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J. Immunol. Methods, 319, 34 40.
36. Petzold, A., Keir, G., Kay, A., Kerr, M. Thompson, E.J. (2006) Axonal damage and outcome in subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry, 77, 753 759.
37. Pike, B.R., Zhao, X., Newcomb, J.K., Posmantur, R.M., Wang, K.K. Hayes, R.L. (1998) Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport, 9, 2437 2442.
38. Pike, B.R., Flint, J., Johnson, E., Glenn, C.C., Dutta, S., Wang, K.K.W. Hayes, R.L. (2001) Accumulation of calpain-cleaved non-erythroid αII-spectrin in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem., 78, 1297 1306.
39. Pike, B.R., Flint, J., Dave, J.R., Lu, X.C., Wang, K.K.W., Tortella, F.C. Hayes, R.L. (2003) Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived αII-spectrin in CSF after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab., 24, 98 106.
40. Pineda, J., Liu, M.C., Aikman, J., Akle, V., Lewis, S., Wang, K.K.W., Robertson, C. Hayes, R.L. (2007) Clinical significance of αII-spectrin breakdown products in CSF after severe traumatic brain injury in human. J. Neurotrauma, 24, 354 366.
41. Raabe, A., Grolms, C. Seifert, V. (1999) Serum markers of brain damage and outcome prediction in patients after severe head injury. Br. J. Neurosurg., 13, 56 59.
42. Ringger, N.C., O' Steen, B.E., Brabham, J.G., Silver, X., Pineda, J., Wang, K.K.W. Hayes, R.L. (2005) A novel marker for traumatic brain injury: CSF αII-spectrin breakdown product levels. J. Neurotrauma, 21, 1443 1456.
43. Roberts-Lewis, J.M. Siman, R. (1993) Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann. N Y Acad. Sci., 679, 78 86.
44. Romner, B., Ingebrigtsen, T., Kongstad, P. Borgesen, S.E. (2000) Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J. Neurotrauma, 17, 641 647.
45. Ross, S.A., Cunningham, R.T., Johnston, C.F. Rowlands, B.J. (1996) Neuron-specific enolase as an aid to outcome prediction in head injury. Br. J. Neurosurg., 10, 471 476.
46. Saigoh, K., Wang, Y.L., Suh, J.G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T. Wada, K. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet., 23, 47 51.
47. Seubert, P., Larson, J., Oliver, M., Jung, M.W., Baudry, M. Lynch, G. (1988) Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus. Brain Res., 460, 189 194.
48. Seubert, P., Lee, K. Lynch, G. (1989) Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res., 492, 366 370.
49. Shaw, G.J., Jauch, E.C. Zemlan, F.P. (2002) Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med., 39, 254 257.
50. Shaw, G., Yang, C., Ellis, R., Anderson, K., Parker Mickle, J., Scheff, S., Pike, B., Anderson, D.K. Howland, D.R. (2005) Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem. Biophys. Res. Commun., 336, 1268 1277.
51. Siman, R. Noszek, J.C. (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron, 1, 279 287.
52. Siman, R., Noszek, J.C. Kegerise, C. (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci., 9, 1579 1590.
53. Siman, R., McIntosh, T.K., Soltesz, K.M., Chen, Z., Neumar, R.W. Roberts, V.L. (2004) Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol. Dis., 16, 311 320.
54. Siman, R., Zhang, C., Roberts, V.L., Pitts-Kiefer, A. Neumar, R.W. (2005) Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J. Cereb. Blood Flow Metab., 25, 1433 1444.
55. Siman, R., Roberts, V.L., McNeil, E., Dang, A., Bavaria, J.E., Ramchandren, S. McGarvey, M. (2008) Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res., 5, 1 11.
56. Sultana, R., Boyd-Kimball, D., Cai, J., Pierce, W.M., Klein, J.B., Merchant, M. Butterfield, D.A. (2007) Proteomics analysis of the Alzheimer's disease hippocampal proteome. J. Alzheimers Dis., 11, 153 164.
57. Tongaonkar, P., Chen, L., Lambertson, D., Ko, B. Madura, K. (2000) Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Mol. Cell. Biol., 20, 4691 4698.
58. Vos, P.E., Lamers, K.J., Hendriks, J.C., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J. Verbeek, M.M. (2004) Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology, 62, 1303 1310.
59. Wang, K.K.W., Ottens, A., Liu, M.C., Lewis, S.B., Meegan, C., Oli, M.W., Tortella, F.C. Hayes, R.L. (2005) Proteomic identification of biomarkers of traumatic brain injury. Expert Rev. Proteomics, 2, 603 614.
60. Wilkinson, K.D. (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J., 11, 1245 1256.
61. Wilkinson, K.D., Deshpande, S. Larsen, C.N. (1992) Comparisons of neuronal (PGP9.5) and non-neuronal ubiquitin C-terminal hydrolases. Biochem. Soc. Trans., 20, 631 637.
62. Yamazaki, Y., Yada, K., Morii, S., Kitahara, T. Ohwada, T. (1995) Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg. Neurol., 43, 267 270.
63. Zaremba, J. Losy, J. (2001) Early TNF-alpha levels correlate with ischemic stroke severity. Acta Neurol. Scand., 104, 288 295.
64. Zemlan, F.P., Jauch, E.C., Mulchahey, J.J., Gabbita, S.P., Rosenberg, W.S., Speciale, S.G. Zuccarello, M. (2002) C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res., 947, 131 139.